Preclinical Evidence for GLP-1 Agonists in Alcohol Use Disorder
Rodent studies show GLP-1 drugs reduce alcohol intake by dampening reward signals in the brain.
Rafael Treviño-Mares
Neuroscience & Delivery Editor
Rafael Treviño-Mares
Rafael Treviño-Mares trained as a pharmacologist and spent seven years at a contract research organization studying central nervous system drug transport before turning to full-time editorial work in 2017. He leads Pathway & Peptide's coverage of intranasal and blood-brain-barrier delivery strategies.
1 story